Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More

Card Electrophysiol Clin. 2015 Dec;7(4):709-20. doi: 10.1016/j.ccep.2015.08.016.

Abstract

Both cardiac resynchronization therapy with a pacemaker (CRT-P) and with a biventricular implantable cardioverter-defibrillator (CRT-D) are electrical treatment modalities validated for the management of chronic heart failure. There is no strong scientific evidence that a CRT-D must be offered to all candidates. Common sense should limit the prescription of these costly and complicated devices. The choice of CRT-P is currently acceptable. A direction to explore could be to downgrade from CRT-D to CRT-P at the time of battery depletion in patients with large reverse remodeling and no ventricular tachycardia and ventricular fibrillation detected.

Keywords: Cardiac resynchronization therapy; Chronic heart failure; Pacemaker.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Cardiac Resynchronization Therapy / mortality
  • Cardiac Resynchronization Therapy / statistics & numerical data*
  • Combined Modality Therapy / mortality
  • Combined Modality Therapy / statistics & numerical data
  • Death, Sudden, Cardiac / epidemiology*
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable / statistics & numerical data*
  • Evidence-Based Medicine
  • Heart Failure / mortality*
  • Heart Failure / prevention & control*
  • Humans
  • Patient Selection
  • Prevalence
  • Prognosis
  • Risk Assessment
  • Survival Rate